Meyka AI API is live for developers.Start building.
Advertisement
Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Kiniksa Pharmaceuticals, Ltd..

KNSA●NASDAQ
HealthcareBiotechnology
$48.42
$0.81(1.65%)
U.S. Market opens in 54h 22m
Advertisement

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

KNSA Technical Analysis Summary

Kiniksa Pharmaceuticals, Ltd. stock currently shows a bearish trend, weighed down by selling pressure and weak momentum.

Overall Sentiment:Sell
Momentum:Bearish to Weak (RSI: 39.90)
Trend Strength:Moderate (ADX: 24.87)
Volatility:Medium (ATR: 2.12)
Support/Resistance:$45.02 – $61.33 (Bollinger Bands)

This mix signals that Kiniksa Pharmaceuticals, Ltd. is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 39.90

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 19.48

Bullish
Oversold zone signals rebound potential.

Williams %R: -79.54

Bearish
Sellers maintain momentum below neutral.

Rate of Change (ROC): -14.47

Strongly Bearish
Sharp downside momentum.

Takeaway:Kiniksa Pharmaceuticals, Ltd. shows weakening momentum, with sellers gaining the edge.

Trend & Volatility

MACD: -1.03

Bearish
Bearish, trend momentum is strengthening to the downside.

ADX: 24.87

Moderate
Moderate trend, direction gaining strength.

ATR (14): 2.12

Medium
Medium volatility, healthy price movement.

CCI (14): -66.68

Bearish
Bearish, momentum remains under pressure.

Takeaway:Kiniksa Pharmaceuticals, Ltd. shows weakening trend signals, with bearish pressure building.

Support & Resistance indicators
Bollinger Bands
Upper Band
$61.33
Middle Band (SMA 20)
$53.17
Lower Band
$45.02
Current Position
Within Bands

Takeaway:Kiniksa Pharmaceuticals, Ltd. trades closer to support, showing weaker momentum within bands.

Keltner Channels
Upper Channel
$55.33
Middle Line (EMA 20)
$51.10
Lower Channel
$46.87
Squeeze Status
No Squeeze

Takeaway:Kiniksa Pharmaceuticals, Ltd. trades below the trend line, showing weaker momentum inside the channel.

Volume & Money Flow Analysis
On-Balance Volume-1.78M
Money Flow Index29.09Bearish, selling pressure outweighs inflows.
Relative Vigor Index39.96Bearish, price momentum favors sellers.

Overall Takeaway:KNSA shows bearish money flow, with sellers dominating volume and vigor.

Technical Trading Signals Summary
Based on the current technical analysis of Kiniksa Pharmaceuticals, Ltd., here are the key trading signals and recommendations:

Bullish Signals

ADX above 20 → strong underlying trend.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

MACD below signal line → short-term caution on momentum.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Kiniksa Pharmaceuticals, Ltd. shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.

Technical Analysis FAQ